Eating This Bacteria May Reduce Risk Of Heart Ailments & Diabetes

 New Delhi: Research has discovered that use of a pasteurised form of Akkermansia muciniphila-an intestinal bacteria reduces the risk of various cardiovascular disease risk factors and diabetes.

According to the findings published in the journal Nature Medicine, the research team from the University of Louvain developed a clinical study in order to administer the bacteria to humans.

For the study, 40 participants were enrolled and 32 completed the trial. The researchers administered Akkermansia to overweight or obese participants, all displaying insulin resistance (pre-diabetes type 2) and metabolic syndrome, in other words, having several elevated risk factors for cardiovascular diseases.

The participants were randomly divided into groups viz. placebo group, those taking live bacteria and those taking pasteurised bacteria and were asked not to change their dietary habits or their physical activity. Akkermansia was provided as a nutritional supplement.

The primary goal of the study was to demonstrate the feasibility of ingesting Akkermansia daily for three months, without risk.

The researchers observed excellent compliance – the supplements were easy to ingest and there were no side effects in the groups taking live or pasteurised bacteria.

According to the study, the tests in humans confirm what had already been observed in mice. Ingestion of the (pasteurised) bacterium prevented the risk of pre-diabetes, cardiovascular issues.

Also Read: IIT Hyderabad Student Commits Suicide In Hostel Room